Van Nieuwenhove, Lagou, Van Eyck, Dooley, Bodenhofer, Roca, Vandebergh, Goris, Humblet-Baron, Wouters and Liston. ‘Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes’. 2019. Annals of the Rheumatic Diseases. 78(5) p617. (IF=12.4)

Humblet-Baron, Franckaert, Dooley, Ailal, Bousfiha, Deswarte, Oleaga-Quintas, Casanova, Bustamante and Liston. ‘IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis’. 2019. Journal of Allergy and Clinical Immunology. In press. (IF=13.1)

Schlenner, Pasciuto, Lagou, Burton, Prezzemolo, Junius, Roca, Seillet, Louis, Dooley, Luong, Van Nieuwenhove, Wicks, Belz, Humblet-Baron, Wouters and Liston. ‘NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathology’. 2019. Annals of the Rheumatic Diseases. 78(3) p342. (IF=12.4)

Liston and Masters. ‘Homeostasis-altering molecular processes as mechanisms of inflammasome activation’. Nature Reviews Immunology. 2017. 17(3) p208. (IF=43)

Carr, Dooley, Garcia-Perez, Lagou, Lee, Wouters, Meyts, Goris, Boeckxstaens, Linterman and Liston. ‘The cellular composition of the human immune system is shaped by age and cohabitation’. Nature Immunology. 2016. 17(4) p461. (IF=20)

Dooley, Tian, Schonefeldt, Delghingaro-Augusto, Garcia-Perez, Pascuito, Di Marino, Carr, Oskolkov, Lyssenko, Franckaert, Lagou, Overbergh, Vandenbussche, Allemeersch, Chabot-Roy, Dahlstrom, Laybutt, Petrovsky, Socha, Gevaert, Jetten, Lambrechts, Linterman, Goodnow, Nolan, Lesage, Schlenner and Liston. ‘Genetic predisposition for beta cell fagility underlies type 1 and type 2 diabetes’. Nature Genetics. 2016. 48(5) p519. (IF=29)

Masters, Lagou, Jeru, Baker, Van Eyck, Parry, Lawless, De Nardo, Garcia-Perez, Dagley, Holley, Dooley, Moghaddas, Pascuito, Jeandel, Sciot, Lyras, Webb, Nicholson, De Somer, van Nieuwenhove, Ruuth-Praz, Copin, Cochet, Medlej-Hashim, Megarbane, Schroder, Savic, Goris, Amselem, Wouters and Liston. ‘Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.’ Science Translational Medicine. 2016. 8(332) p45. (IF=16)

Liston and Gray. ‘Homeostatic control of regulatory T cell diversity’. 2014. Nature Reviews Immunology. 14(3):154. (IF=33.1)

Pierson, Cauwe, Policheni, Schlenner, Franckaert, Berges, Humblet-Baron, Schonefeldt, Herold, Hildeman, Strasser, Bouillet, Lu, Matthys, Freitas, Luther, Weaver, Dooley, Gray and Liston. ‘Anti-apoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells.’ 2013. Nature Immunology. 14(9) p959. (IF=26.2)

Papadopoulou, Dooley, Linterman, Pierson, Ucar, Kyewski, Zuklys, Hollander, Matthys, Gray, De Strooper and Liston. 'The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor.' 2012. Nature Immunology. 13 p181. (IF=26.2)

Linterman, Pierson, Lee, Kallies, Kawamoto, Rayner, Srivastava, Divekar, Beaton, Hogan, Fagarasan, Liston*, Smith* and Vinuesa*. *Co-last. 'Follicular regulatory T cells develop from FoxP3+ T cells and control T follicular helper cells and the germinal center response'. 2011. Nature Medicine. 17(8) p975. (IF=22.9)

Liston, Enders and Siggs. ‘Unravelling the clinical association of partial T-cell immunodeficiency and immune dysregulation with mouse models’ 2008. Nature Reviews Immunology. 8(7) p545. (IF=33.1)

Siggs, Miosge, Yates, Kuchsarka, Sheahan, Brdicka, Weiss, Liston* and Goodnow*. ‘Opposing functions of Zap70 for immunity and tolerance titrate differentially in response to inherited single nucleotide substitutions’. 2007. Immunity. 27(6) p912. *equal contribution senior authors. (IF=21.5)

Liston, Lesage, Gray, O’Reilly, Strasser, Fahrer, Boyd, Wilson, Baxter, Gallo, Crabtree, Peng, Wilson and Goodnow. ‘Generalised resistance to thymic deletion in the NOD mouse: a polygenic trait characterized by defective induction of Bim’. 2004. Immunity 21(6) p817. (IF=21.5)